Intero Biosystems offers lab-grown human intestines to drugmakers as animal testing alternative
Intero Biosystems is now selling lab-grown miniature human intestines to pharmaceutical companies. The move comes as regulators increasingly push for alternatives to animal testing. The startup aims to scale up production of these organoids. It also plans to broaden the uses of its organoid technology.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.


Discussion (0)
Log in to join the discussion and vote.
Log in